Literature DB >> 2448255

Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production.

H Mori1, M Mihara, K Teshima, U Uesugi, Q Xu, O Sakamoto, A Koda.   

Abstract

OK-432, a lyophilized preparation of Streptococcus pyogenes, showed a priming activity for TNF production in mice, associated with an increase of spleen weight. PSK, a protein-bound polysaccharide preparation from Coriolus versicolor, did not show such activity. Both OK-432 and PSK potentiated the TNF production in mice primed with Corynebacterium parvum (CP) and challenged with Escherichia coli endotoxin (LPS). Cytotoxic antitumor agents of 5-fluorouracil (5-FU), cyclophosphamide (CY) and bleomycin (BLM) suppressed TNF production in mice primed with CP and challenged with LPS. TNF production suppressed by 5-FU, CY and BLM was partially restored by the combined treatment with OK-432 or PSK. These results suggest that the administration of cytotoxic antitumor agents suppresses the intrinsic TNF production in cancer patients, and the combined use of immunostimulants such as OK-432 and PSK is advantageous in restoring TNF production suppressed by cytotoxic antitumor agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448255     DOI: 10.1016/0192-0561(87)90004-x

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  3 in total

1.  Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.

Authors:  H Fukui; C W Reynolds; B Lenz; M Schneider; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages.

Authors:  Kazue Nakata; Hiroyuki Inagawa; Takashi Nishizawa; Teruko Honda; Chie Kohchi; Yasuhito Tonomoto; Hiroshi Yoshimura; Naofumi Nagasue; Shynji Natori; Hiroshi Terada; Gen-Ichiro Soma
Journal:  Int J Colorectal Dis       Date:  2005-08-10       Impact factor: 2.571

Review 3.  Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.